| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Investments &CLO | EVP, Investments &GC
1 company
Lloyd George W. is an EVP, Investments &CLO at Royalty Pharma plc. Recent SEC Form 4 filings include 0 buys and 41 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2022 | RPRX Royalty Pharma Plc | EVP, Investments &GC | Sell | 75,100 | $43.25 | $3,248,199.30 | -3.8% | -4.7% | -28.4% | |
| May 27, 2022 | RPRX Royalty Pharma Plc | EVP, Investments &GC | Sell | 100,000 | $40.29 | $4,029,091.25 | -10.3% | +6.2% | -20.9% | |
| May 23, 2022 | RPRX Royalty Pharma Plc | EVP, Investments &GC | Sell | 100,000 | $40.27 | $4,026,770.00 | -15.9% | +9.4% | -16.7% | |
| Nov 17, 2021 | RPRX Royalty Pharma Plc | EVP, Investments &GC | Sell | 250,000 | $42.39 | $10,596,693.28 | -9.6% | -4.7% | +1.9% | |
| Jul 26, 2021 | RPRX Royalty Pharma Plc | EVP, Investments &GC | Sell | 13,362 | $39.78 | $531,532.49 | -1.0% | -4.7% | +10.3% | |
| Jul 13, 2021 | RPRX Royalty Pharma Plc | EVP, Investments &GC | Sell | 23,149 | $42.01 | $972,455.99 | -1.0% | -13.1% | +3.3% | |
| Jul 8, 2021 | RPRX Royalty Pharma Plc | EVP, Investments &GC | Sell | 88,489 | $42.19 | $3,733,761.56 | -2.0% | -13.5% | +5.7% | |
| Jun 10, 2021 | RPRX Royalty Pharma Plc | EVP, Investments &GC | Sell | 70,000 | $46.49 | $3,254,369.00 | -3.9% | -16.6% | -11.6% | |
| Jun 8, 2021 | RPRX Royalty Pharma Plc | EVP, Investments &GC | Sell | 252,500 | $46.01 | $11,616,797.43 | -3.2% | -15.7% | -9.1% | |
| Jun 2, 2021 | RPRX Royalty Pharma Plc | EVP, Investments &GC | Sell | 62,500 | $42.12 | $2,632,512.50 | -3.4% | -9.7% | -3.9% |